Gastroesophageal Junction Carcinoma
11 clinical trials · Condition
◉ Watch Gastroesophageal Junction Carcinoma
| Record | Firm | Date |
|---|---|---|
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (NCT05059444) | Guardant Health, Inc. | 2021-09-07 |
| Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors (NCT04900818) | I-Mab Biopharma US Limited | 2021-06-29 |
| A Study of SGN-STNV in Advanced Solid Tumors (NCT04665921) | Seagen Inc. | 2021-01-18 |
| A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer (NCT04254107) | Seagen Inc. | 2020-05-29 |
| Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma (NCT00256321) | University of California, Irvine | 2004-10-01 |
Track Gastroesophageal Junction Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.